Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts-Reference-Cited by-同舟云学术

Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts

Published:2009-12 Issue:6 Volume:175 Page:2392-2405
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Fickert Peter,Fuchsbichler Andrea,Moustafa Tarek,Wagner Martin,Zollner Gernot,Halilbasic Emina,Stöger Ulrike,Arrese Marco,Pizarro Margarita,Solís Nancy,Carrasco Gonzalo,Caligiuri Alessandra,Sombetzki Martina,Reisinger Emil,Tsybrovskyy Oleksiy,Zatloukal Kurt,Denk Helmut,Jaeschke Hartmut,Pinzani Massimo,Trauner Michael

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference42 articles.

1. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations;Zollner;Mol Pharm,2006

2. FXR, a multipurpose nuclear receptor;Lee;Trends Biochem Sci,2006

3. Nuclear bile acid receptor FXR as pharmacological target: are we there yet?;Modica;FEBS Lett,2006

4. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity;Chen;Gastroenterology,2004

5. Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans;Kovacs;J Hepatol,2008

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Narrative Review: Immunometabolic Interactions of Host–Gut Microbiota and Botanical Active Ingredients in Gastrointestinal Cancers;International Journal of Molecular Sciences;2024-08-22

2. Metabolic reprogramming in liver fibrosis;Cell Metabolism;2024-07

3. Novel preclinical developments of the primary sclerosing cholangitis treatment landscape;Expert Opinion on Investigational Drugs;2024-03-18

4. Targeting nuclear receptors for NASH/MASH: From bench to bedside;Liver Research;2024-03

5. 3D‐Printed Lipid Mesophases for the Treatment of Chronic Liver Disease;Advanced Materials Technologies;2024-02-21